Abatacept as salvage therapy for life-threatening refractory autoimmune hemolytic anemia: a case report
Autoimmune hemolytic anemia (AIHA) can be life-threatening, if hemoglobin (Hb) levels continue to decline after established treatments with glucocorticoids, rituximab, intravenous immunoglobulins, and plasmapheresis. Impaired regulatory T cells (Treg) are proposed to alleviate AIHA development th...
Spremljeno u:
Glavni autori: | , , |
---|---|
Format: | Članak |
Jezik: | engleski |
Izdano: |
Philipps-Universität Marburg
2023
|
Teme: | |
Online pristup: | PDF cijeli tekst |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
Budi prvi tko komentira!